JP2020516671A5 - - Google Patents

Download PDF

Info

Publication number
JP2020516671A5
JP2020516671A5 JP2019556238A JP2019556238A JP2020516671A5 JP 2020516671 A5 JP2020516671 A5 JP 2020516671A5 JP 2019556238 A JP2019556238 A JP 2019556238A JP 2019556238 A JP2019556238 A JP 2019556238A JP 2020516671 A5 JP2020516671 A5 JP 2020516671A5
Authority
JP
Japan
Prior art keywords
methyl
compound
acid
triazole
sulfanyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019556238A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020516671A (ja
JP7241025B2 (ja
Filing date
Publication date
Priority claimed from IT102017000041723A external-priority patent/IT201700041723A1/it
Application filed filed Critical
Publication of JP2020516671A publication Critical patent/JP2020516671A/ja
Publication of JP2020516671A5 publication Critical patent/JP2020516671A5/ja
Priority to JP2022164773A priority Critical patent/JP2022191395A/ja
Application granted granted Critical
Publication of JP7241025B2 publication Critical patent/JP7241025B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019556238A 2017-04-14 2018-04-12 選択的hdac6阻害剤 Active JP7241025B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022164773A JP2022191395A (ja) 2017-04-14 2022-10-13 選択的hdac6阻害剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102017000041723A IT201700041723A1 (it) 2017-04-14 2017-04-14 Nuovi inibitori selettivi di HDAC6
IT102017000041723 2017-04-14
PCT/EP2018/059468 WO2018189340A1 (en) 2017-04-14 2018-04-12 Selective hdac6 inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022164773A Division JP2022191395A (ja) 2017-04-14 2022-10-13 選択的hdac6阻害剤

Publications (3)

Publication Number Publication Date
JP2020516671A JP2020516671A (ja) 2020-06-11
JP2020516671A5 true JP2020516671A5 (cg-RX-API-DMAC10.html) 2020-12-17
JP7241025B2 JP7241025B2 (ja) 2023-03-16

Family

ID=59700099

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019556238A Active JP7241025B2 (ja) 2017-04-14 2018-04-12 選択的hdac6阻害剤
JP2022164773A Withdrawn JP2022191395A (ja) 2017-04-14 2022-10-13 選択的hdac6阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022164773A Withdrawn JP2022191395A (ja) 2017-04-14 2022-10-13 選択的hdac6阻害剤

Country Status (30)

Country Link
US (1) US11351178B2 (cg-RX-API-DMAC10.html)
EP (1) EP3562810B1 (cg-RX-API-DMAC10.html)
JP (2) JP7241025B2 (cg-RX-API-DMAC10.html)
KR (1) KR102525375B1 (cg-RX-API-DMAC10.html)
CN (1) CN110546140B (cg-RX-API-DMAC10.html)
AR (1) AR111466A1 (cg-RX-API-DMAC10.html)
AU (1) AU2018252172B9 (cg-RX-API-DMAC10.html)
CA (1) CA3056381A1 (cg-RX-API-DMAC10.html)
CL (1) CL2019002869A1 (cg-RX-API-DMAC10.html)
CO (1) CO2019011993A2 (cg-RX-API-DMAC10.html)
CY (1) CY1126110T1 (cg-RX-API-DMAC10.html)
DK (1) DK3562810T3 (cg-RX-API-DMAC10.html)
ES (1) ES2951476T3 (cg-RX-API-DMAC10.html)
FI (1) FI3562810T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20230789T8 (cg-RX-API-DMAC10.html)
HU (1) HUE063079T2 (cg-RX-API-DMAC10.html)
IL (1) IL268955B (cg-RX-API-DMAC10.html)
IT (1) IT201700041723A1 (cg-RX-API-DMAC10.html)
LT (1) LT3562810T (cg-RX-API-DMAC10.html)
MX (1) MX2019011876A (cg-RX-API-DMAC10.html)
NZ (1) NZ756603A (cg-RX-API-DMAC10.html)
PE (1) PE20200446A1 (cg-RX-API-DMAC10.html)
PL (1) PL3562810T3 (cg-RX-API-DMAC10.html)
PT (1) PT3562810T (cg-RX-API-DMAC10.html)
RS (1) RS64376B1 (cg-RX-API-DMAC10.html)
RU (1) RU2764718C2 (cg-RX-API-DMAC10.html)
SI (1) SI3562810T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202300228T1 (cg-RX-API-DMAC10.html)
TW (1) TWI813564B (cg-RX-API-DMAC10.html)
WO (1) WO2018189340A1 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018165520A1 (en) 2017-03-10 2018-09-13 Vps-3, Inc. Metalloenzyme inhibitor compounds
CN109942564A (zh) * 2019-04-16 2019-06-28 四川大学华西医院 一种组蛋白去乙酰化酶抑制剂及其制备方法和用途
CN115443329A (zh) 2019-06-27 2022-12-06 乔治华盛顿大学国会特许非营利公司 Hdac6激活的巨噬细胞、其组合物及用途
US20220251043A1 (en) * 2019-07-23 2022-08-11 Taipei Medical University Histone deacetylase 6 inhibitors and method for treating neuropathic pain
WO2021021979A2 (en) 2019-07-30 2021-02-04 Eikonizo Therapapeutics, Inc. Hdac6 inhibitors and uses thereof
CR20220325A (es) 2019-12-20 2022-08-19 Tenaya Therapeutics Inc Fluoroalquil-oxadiazoles y sus usos
MX2023001086A (es) * 2020-08-07 2023-03-23 Italfarmaco Spa Nuevos inhibidores selectivos de histona desacetilasa 6 (hdac6) basados en oxadiazol.
CN112250638B (zh) * 2020-11-13 2022-05-03 郑州大学 一种1,3-二芳基-1,2,4-三氮唑类化合物及其制备方法和应用
IT202100009926A1 (it) 2021-04-20 2022-10-20 Italfarmaco Spa Una combinazione comprendente un inibitore di hdac6 specifico e almeno un inibitore del checkpoint ctla4
TW202340480A (zh) 2021-11-23 2023-10-16 義大利商義大利藥品股份有限公司 檢測rna生物標記之方法
WO2023219456A1 (ko) * 2022-05-12 2023-11-16 숙명여자대학교 산학협력단 퀴놀린 계열 히스톤디아세틸화 효소 저해활성물질, 이의 제조방법 및 이를 유효성분으로 포함하는 약학적 조성물
EP4595976A1 (en) * 2022-09-27 2025-08-06 Samsung Life Public Welfare Foundation Composition for treating cancer containing histone deacetylase inhibitor, and anticancer adjuvant for cancer immunotherapy
CN115611823B (zh) * 2022-10-27 2024-09-27 新天地医药技术研究院(郑州)有限公司 一种1,2,4-三氮唑-苯基异羟肟酸类化合物、制备方法和应用
CN115737549A (zh) * 2022-11-24 2023-03-07 北京鑫开元医药科技有限公司 一种具有hdac抑制活性的注射液及其制备方法和用途
IL321862A (en) * 2023-01-06 2025-08-01 Sparrow Pharmaceuticals Inc Methods and compounds for treating disorders caused by HSD-1

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2473510A1 (en) 2002-01-23 2003-07-31 Bayer Pharmaceuticals Corporation Pyrimidine derivatives as rho-kinase inhibitors
EP1765814A1 (en) 2004-07-02 2007-03-28 Novo Nordisk A/S Condensed thiophene derivatives and their use as cyclic glp-1 agonists
GB0607899D0 (en) 2006-04-03 2006-05-31 Glaxo Group Ltd Process for preparing heterocyclic derivatives
US20090005374A1 (en) 2007-06-26 2009-01-01 Melvin Jr Lawrence S Imidazopyridinyl thiazolyl histone deacetylase inhibitors
CA2765678A1 (en) * 2009-06-22 2010-12-29 Christopher Blackburn Substituted hydroxamic acids and uses thereof
US20120101099A1 (en) * 2009-07-07 2012-04-26 Anthem Biosciences Private Limited Histone deacetylase inhibitors
JP5518397B2 (ja) 2009-08-12 2014-06-11 富士フイルム株式会社 水性インク組成物、複合粒子の製造方法、インクセット、及び、画像形成方法
WO2011106650A2 (en) 2010-02-27 2011-09-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease
EA025345B1 (ru) * 2010-11-16 2016-12-30 Эситайлон Фармасьютикалз, Инк. Гидроксиамидные соединения пиримидина в качестве ингибиторов деацетилаз белков и фармацевтические композиции для лечения заболевания, обусловленного hdac6, включающие эти соединения
CA2825599C (en) * 2011-02-01 2021-07-13 The Board Of Trustees Of The University Of Illinois 4-methyl-n-hydroxybenzamide compounds as histone deacetylase (hdac) inhibitors
EP2487159A1 (en) 2011-02-11 2012-08-15 MSD Oss B.V. RorgammaT inhibitors
US20150197497A1 (en) * 2011-06-24 2015-07-16 Dana-Farber Cancer Institute, Inc. Selective inhibitors of histone deacetylase isoform 6 and methods thereof
ES2704704T3 (es) 2013-12-12 2019-03-19 Chong Kun Dang Pharmaceutical Corp Nuevos derivados de azaindol como inhibidores selectivos de la histona desacetilasa (HDAC) y composiciones farmacéuticas que los comprenden
KR101685639B1 (ko) 2014-01-03 2016-12-12 주식회사 종근당 신규한 인돌 유도체 화합물 및 이를 포함하는 약제학적 조성물
TW201625620A (zh) * 2014-05-14 2016-07-16 美國科羅拉多州立大學 作為蛋白去乙醯酶抑制劑及雙蛋白去乙醯酶蛋白激酶抑制劑之雜環氧肟酸及其使用方法
KR102567244B1 (ko) * 2014-06-12 2023-08-16 세다르스-신나이 메디칼 센터 암을 치료하는 조성물 및 방법

Similar Documents

Publication Publication Date Title
JP2020516671A5 (cg-RX-API-DMAC10.html)
RU2019132212A (ru) Селективные ингибиторы hdac6
RU2317291C2 (ru) Производные пиримидина в качестве модуляторов рецептора инсулинподобного фактора роста 1 (igf-1), фармацевтическая композиция, способы получения (варианты) и применение
JP2019517455A5 (cg-RX-API-DMAC10.html)
JP5674828B2 (ja) Pde10インヒビターならびに関連する組成物および方法
RU2439068C2 (ru) Модуляторы mglur5
JP2010533158A5 (cg-RX-API-DMAC10.html)
JP2018535999A5 (cg-RX-API-DMAC10.html)
JP2014511869A5 (cg-RX-API-DMAC10.html)
JP2017505762A5 (cg-RX-API-DMAC10.html)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2016164184A5 (cg-RX-API-DMAC10.html)
RU2018138707A (ru) Замещенные гетероарилом пиридины и способы применения
JP2014525444A5 (cg-RX-API-DMAC10.html)
JP2007510689A5 (cg-RX-API-DMAC10.html)
JP2008546836A (ja) 新規な用途
JP2007530690A5 (cg-RX-API-DMAC10.html)
JP2019518036A5 (cg-RX-API-DMAC10.html)
JP2010505809A5 (cg-RX-API-DMAC10.html)
JP2010510242A5 (cg-RX-API-DMAC10.html)
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
JP2007523208A5 (cg-RX-API-DMAC10.html)
JP2006503081A5 (cg-RX-API-DMAC10.html)
JP2010513438A5 (cg-RX-API-DMAC10.html)
JP2018507234A5 (cg-RX-API-DMAC10.html)